Appendix 4D – Half Yearly Report for Dec, 2017 Financial Reports 2018, News & Announcements 2018By PharmAustMarch 1, 2018R
PharmAust receives $354k R&D Tax Incentive Refund News & Announcements 2018By PharmAustFebruary 28, 2018180127_R&D Refund
Top 20 Shareholders Feb 2018 Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAustFebruary 26, 2018Top holder 20_Feb 2018
Results of General Meeting Financial Reports 2018, News & Announcements 2018By PharmAustFebruary 26, 2018180226_EGM Results
Appendix 4C and Shareholders Update (Q2, 2018 FY) Financial Reports 2018, News & Announcements 2018By PharmAustJanuary 31, 2018180131_Quarterley&Shareholders Update_PAA
Monepantel reformulation successfully increases dose and improves taste News & Announcements 2018By PharmAustJanuary 30, 2018BRI update_clean
NOTICE OF GENERAL MEETING AND EXPLANATORY STATEMENT Financial Reports 2018, News & Announcements 2018By PharmAustJanuary 29, 2018180129_Notice of General Meeting
Epichem Awarded One Year Contract Extension from DNDi News & Announcements 2018By PharmAustJanuary 18, 2018180118_dndi-announcement_(clean)
International Vet Cancer Specialist Joins PharmAust Veterinary Advisory Board News & Announcements 2017By PharmAustDecember 17, 2017171211_B Kitchell SAB appointment_(clean)